The Bio-Belt: Growing the Future in Rural America

Agtech successes like Pivot Bio and JOYN are great news for the biotech coasts, but rural America is left in a bind without the biotechnology infrastructure to create jobs and maintain US competitiveness. Getty Strategic investment in biotechnology now would reinvigorate rural America and help secure our nation’s high-tech competitive […]

Here’s Why Intrexon Jumped 58% in June

What happenedShares of Intrexon (NASDAQ: XON) jumped 58% in June, according to data provided by S&P Global Market Intelligence, after the biotech announced a $100 million deal with Surterra Wellness, a privately held medical cannabis company that will use Intrexon’s yeast fermentation technology to produce cannabinoids.So whatThe deal expands on a partnership between Intrexon and…

Biogen Hedged Its Bet and Won Big

Sometimes a drugmaker’s best move isn’t developing a new drug but protecting sales of an established one.Sales of Biogen’s (NASDAQ: BIIB) top-selling multiple sclerosis drug Tecfidera brought in almost $4.3 billion last year, and sales are on pace to be even higher this year. Much of that sales volume was at risk with Alkermes (NASDAQ:…

Here’s Why Axsome Therapeutics Stock Rocketed 813% in the First Half of 2019

What happenedShares of Axsome Therapeutics (NASDAQ: AXSM), an overlooked biopharmaceutical company that began 2019 with an $85 million market cap, finished the first half of the year worth $858 million. Investors have been flocking toward Axsome thanks to the potential launch of a drug for treatment-resistant major depressive disorder (MDD). According to data from S&P Global…